Revolutionary COVID-19 Patient Isolation Transport System Minimizes Infection Risk to Medical Personnel
By HospiMedica International staff writers Posted on 01 Jul 2020 |
Image: Numobag Disposable Isolation System (Photo courtesy of Numotech, Inc.)
A new infectious disease containment system could provide protection to critical first responders and medical staff against infectious or contagious disease, such as COVID-19, while transporting or monitoring an infected patient.
The new production-ready Numobag Disposable Isolation System (N-DIS) from Numotech, Inc. (Northridge, CA, USA) is a portable, easily deployed, low-cost, single-use, disposable infectious disease containment system designed to minimize risk to the patient and front-line personnel, while allowing patient monitoring and safe transport fully encapsulated in a medical-grade, oxygen-enriched, clear polyethylene membrane. The N-DIS is an innovative adaptation of Numotech's premier wound care product, the Numobag, a unique oxygen-bath device for healing severe burns, advanced stage wounds, sores, flesh-eating bacteria, and diabetic and pressure ulcers.
The N-DIS external exhaust filtering system uses high-flow, low-pressure HEPA filters certified to remove more than 99.99% of viral and bacterial contamination from the patient's exhaled breath, protecting the transport and/or monitoring work environment (air and surfaces) of the first responders and medical personnel. The N-DIS provides fully contained protection during patient transit from today's COVID-19, as well as other infectious/contagious pathogens. The simple-to-use, low-cost, disposable isolation system meets all quarantine protocols and protects medical staff from exposure to infectious and contagious diseases. This is important because front-line medical and first responders worldwide have the second highest rates of serious illness and death from COVID-19, surpassed only by the world's elderly population. Additionally, vulnerable patients such as burn victims, those recovering from cancer treatments, or those with compromised immune systems are particularly susceptible to airborne pathogens, and the N-DIS also fully isolates and protects them during transport.
“Along with rapid isolation of the patient, another critical operational consideration is patient safety,” said Robert Felton, President of Numotech. “The emplacement of the N-DIS does not cause undue physical discomfort for the patient, which would impede rapid and effective isolation. The ability to introduce medical grade oxygen enhances the environment for a patient, while containing and disposing of contaminated exhaust allows the patient to be transported and monitored comfortably and safely.”
Related Links:
Numotech, Inc.
The new production-ready Numobag Disposable Isolation System (N-DIS) from Numotech, Inc. (Northridge, CA, USA) is a portable, easily deployed, low-cost, single-use, disposable infectious disease containment system designed to minimize risk to the patient and front-line personnel, while allowing patient monitoring and safe transport fully encapsulated in a medical-grade, oxygen-enriched, clear polyethylene membrane. The N-DIS is an innovative adaptation of Numotech's premier wound care product, the Numobag, a unique oxygen-bath device for healing severe burns, advanced stage wounds, sores, flesh-eating bacteria, and diabetic and pressure ulcers.
The N-DIS external exhaust filtering system uses high-flow, low-pressure HEPA filters certified to remove more than 99.99% of viral and bacterial contamination from the patient's exhaled breath, protecting the transport and/or monitoring work environment (air and surfaces) of the first responders and medical personnel. The N-DIS provides fully contained protection during patient transit from today's COVID-19, as well as other infectious/contagious pathogens. The simple-to-use, low-cost, disposable isolation system meets all quarantine protocols and protects medical staff from exposure to infectious and contagious diseases. This is important because front-line medical and first responders worldwide have the second highest rates of serious illness and death from COVID-19, surpassed only by the world's elderly population. Additionally, vulnerable patients such as burn victims, those recovering from cancer treatments, or those with compromised immune systems are particularly susceptible to airborne pathogens, and the N-DIS also fully isolates and protects them during transport.
“Along with rapid isolation of the patient, another critical operational consideration is patient safety,” said Robert Felton, President of Numotech. “The emplacement of the N-DIS does not cause undue physical discomfort for the patient, which would impede rapid and effective isolation. The ability to introduce medical grade oxygen enhances the environment for a patient, while containing and disposing of contaminated exhaust allows the patient to be transported and monitored comfortably and safely.”
Related Links:
Numotech, Inc.
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans